Dr Reddy’s Laboratories, India’s second-largest drug maker by sales after Ranbaxy, maintained its revenue growth forecast at 10% forthis fiscal, despite pricing pressures in Germany and a shrinking pharma market in Russia.
Read »Dr Reddy’s Laboratories, India’s second-largest drug maker by sales after Ranbaxy, maintained its revenue growth forecast at 10% forthis fiscal, despite pricing pressures in Germany and a shrinking pharma market in Russia.
Read »